
Acral lentiginous melanoma is a serious and aggressive form of skin cancer. It grows on the palms, soles, or under the nails. It often looks like a brown patch or a changing spot, making it hard to spot during routine checks.
This condition is not caused by sun exposure. So, it’s a hidden threat that doctors need to watch out for. Catching it early is key to better treatment and outcomes.
We created this guide for international patients to understand acral lentiginous melanoma better. Our aim is to give you clear, reliable info. This way, you can spot symptoms early and get medical help fast.
We mix medical knowledge with care to support you. We’re here to help you find the right diagnosis and treatment. We want to guide you through your health journey with confidence and expertise.
Key Takeaways
- This condition typically develops on the palms, soles, or nail beds.
- It is not caused by sun exposure, making it distinct from other skin cancers.
- Early identification of irregular spots is vital for successful treatment.
- Professional medical evaluation is necessary for an accurate diagnosis.
- We offer expert support to help international patients access specialized care.
Understanding Acral Lentiginous Melanoma Rare Types and Demographics

It’s important to know the patterns of acral lentiginous melanoma to catch it early. This skin cancer is different from others because it’s not caused by sun damage. We want to explain how it shows up in certain body parts.
Defining the Condition
Acrolentiginous melanoma is a rare skin cancer. It often shows up on hands, feet, and under nails. Because it’s in areas not often exposed to UV light, it’s often missed during skin checks.
Look out for changing spots or dark streaks under nails. These are signs of melanoma on the palm or foot. Catching these early is key to treating it well. Keep an eye on any unusual spots on your hands or feet.
Prevalence Across Different Populations
The disease is more common in some groups than others. In Caucasians, it makes up 2 to 3 percent of melanoma cases. But in darker-skinned people, it’s the most common type.
In Asian and African-American communities, acral lentigious melanoma makes up 40 to 60 percent of melanoma cases. This shows why it’s so important to raise awareness in diverse groups. Knowing these numbers helps us support those at higher risk better.
Age and Risk Factors
People are usually diagnosed with this condition at 63 years old. Unlike other skin cancers, melanoma on palm of hand or foot isn’t caused by sun exposure. It’s linked to unique biological and genetic factors we’re studying.
The table below shows the main demographic differences in melanoma acral lentiginoso:
| Population Group | Prevalence of ALM | Primary Location |
| Caucasian | 2% – 3% | Hands and Feet |
| Asian | 40% – 60% | Palms and Soles |
| African-American | 40% – 60% | Nail Beds and Soles |
If you’re worried about melanoma on hands or a strange spot on your foot, see a doctor. We’re here to help you understand melanoma palm of hand symptoms with care and knowledge.
Causes, Clinical Signs, and Progression of the Disease

This type of skin cancer is different from others. It doesn’t usually come from sun exposure. Instead, it’s caused by internal and local factors that need careful watching.
The Role of Mechanical Stress and Trauma
Studies show that long-term pressure and injury are big factors. Tight shoes can cause irritation, leading to acral lentiginous melanoma foot. This is a big worry for the skin on our lower legs.
Repeating stress on fingers can also cause acral lentiginous melanoma on toe. Even small injuries can start abnormal cell growth. It’s important to watch for changes in an acral lentiginous melanoma toe to prevent it.
Genetic Mutations and Biological Drivers
Genetic markers also play a part in this disease. Scientists have found mutations in genes like KIT and BRAF. These are key for doctors to spot the disease early.
Knowing these mutations helps doctors diagnose better. This genetic insight helps us tell this cancer apart from others. It’s a big part of our research and care.
Identifying Early Stage Acral Lentiginous Melanoma
Spotting it early is key for treatment success. An early stage acral lentiginous melanoma looks like a flat, dark spot. A brown freckle on palm of hand that doesn’t change is a sign.
Look out for freckles on soles of feet with odd shapes or colors. An early melanoma hand might show a melanoma gray or blue color. If you see a melanoma freckle on finger or odd melanoma on soles of feet, get it checked right away.
Progression to Advanced Stages
If not treated, it can grow slowly over time. The flat spot may get thicker and more serious. This is when it turns into a melanoma plantar condition.
In later stages, the spots can grow and get ulcers. Early detection is the best way to stop it. Knowing the signs helps you take care of your skin.
Conclusion
Early detection is key to better health outcomes. Spotting unusual skin changes early leads to quick medical action.
Being alert during self-exams is vital for catching stage 1 melanoma on your palm. Keep an eye out for any new or changing spots on your hands and feet.
Our team offers top-notch care for those facing this diagnosis. We provide detailed support to ensure you get the best treatment for your needs.
Don’t wait to get a professional skin check from a skilled dermatologist. Getting expert advice helps manage your health better and gives you peace of mind.
Contact our specialists today to talk about your health concerns. We’re here to support you every step of the way.
FAQ
What exactly is acrolentiginous melanoma and where does it typically appear?
What are the primary acral lentiginous melanoma causes?
How can I identify early stage acral lentiginous melanoma?
Does the color of the lesion help in identifying a melanoma on palm of hand or foot?
Who is most at risk for developing this specific form of melanoma?
What is the typical progression of an acral lentiginous melanoma on toe or heel?
FAQ
What is Acral Lentiginous Melanoma?
Acral Lentiginous Melanoma (ALM) is a rare type of melanoma that develops on the palms of the hands, soles of the feet, or under the nails. Unlike other melanomas, it is not strongly linked to sun exposure. It is more commonly seen in people with darker skin tones, but it can affect anyone.
What causes Acral Lentiginous Melanoma?
The exact cause is not fully understood. Unlike other skin cancers, ALM is not primarily caused by UV radiation. It is thought to develop due to genetic mutations in skin cells over time. Because it appears in less visible areas, it is often detected later, which can make it more serious if not diagnosed early.
What are the early signs of Acral Lentiginous Melanoma?
Early signs may include a dark brown or black streak under a nail, a growing dark patch on the palm or sole, or a spot that changes in size, shape, or color. It may also bleed, become painful, or develop an irregular border. Any new or changing lesion in these areas should be checked by a doctor.
How is Acral Lentiginous Melanoma diagnosed?
Diagnosis usually involves a skin examination followed by a biopsy of the suspicious area. Doctors may also use dermoscopy or imaging tests to evaluate how deep the melanoma has grown and whether it has spread to lymph nodes or other organs.
What are the treatment options for Acral Lentiginous Melanoma?
Treatment depends on the stage of the cancer. Early-stage ALM is usually treated with surgical removal of the tumor. In more advanced cases, treatment may include lymph node removal, immunotherapy, targeted therapy, radiation, or chemotherapy depending on how far the cancer has spread.
Is Acral Lentiginous Melanoma more dangerous than other melanomas?
ALM is not inherently more aggressive, but it is often diagnosed later because it appears in less visible areas like the soles of the feet or under nails. Late detection can make it more advanced at the time of diagnosis, which can affect outcomes.
What is the recovery process after treatment?
Recovery depends on the stage and treatment type. After surgery, patients may need wound care and follow-up visits. If advanced treatment is required, ongoing monitoring, scans, and systemic therapy may be needed. Regular skin and lymph node checks are important to detect recurrence early.
References
National Center for Biotechnology Information. https://pubmed.ncbi.nlm.nih.gov/10718682/)



